3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Gastrointestinal
4
Tumor-Agnostic
3
Thoracic
2
Plasma cell
1
Head & Neck
1
Classical hematology
1
Breast
1
Conditions
Stress Disorders, Post-Traumatic
1
Parkinson Disease
1
Pain, Intractable
1
Neoplasms
1
Muscle Spasticity
1
Multiple Sclerosis
1
Inflammatory Bowel Diseases
1
Huntington Disease
1
Glaucoma
1
Epilepsy
1
Dyskinesias
1
Autism Spectrum Disorder
1
Anemia, Sickle Cell
1
Acquired Immunodeficiency Syndrome
1
Interventions
Rivaroxaban
8
Surveys and Questionnaires
7
Heparin, Low-Molecular-Weight
5
apixaban
4
fludarabine
3
Blood Specimen Collection
3
pegfilgrastim
2
epoetin beta
2
Therapeutics
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Observation
2
Microarray Analysis
2
Melphalan
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Flow Cytometry
2
Epoetin Alfa
2
Data Collection
2
Dabigatran
2
Biopsy
2
ziprasidone
1
ribociclib
1
ravulizumab
1
palbociclib
1
oprelvekin
1
iron isomaltoside 1000
1
fludarabine phosphate
1
edoxaban
1
calcium heparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Registries
×
Classical hematology
×
Clear all
NCT03886753
2020-07-30
Ilera
Children's Hospital of Philadelphia
Terminated
10 enrolled